Cellebrite DI : CLBT Q125 Historical Financial Tables and Supplemental Data
CLBT
Published on 05/14/2025 at 08:05
Cellebrite DI Ltd. Condensed and Consolidated - US GAAP Income Statements (U.S. Dollars in thousands, except share and per share data - unauditedl
31-Mar
Quarter Ended
30-Jun 30-Sep 31-Dec
Quarter Ended 31-Mar
Revenue:
Subscription services Term-license
Total subscription Other non-recurring* Professional services
Total revenue
$ 62,103 $ 65,738 $ 69,339 $ 73,868
17,14P 49,630 26,038 21,220 79,222 85,068 93,377 95,068
3,5é8 3,186 3,938 5,293
6,792 6,880 9,543 7,688
89,582 95,714 106,858 109,049
$ 76,688
49,464
95,829
J,411 7,309
107,549
Yr Ended
31- Dec
$ 55,890
60,053
215,963
21,215
33,4é3
270,651
1 7,107
685
1 2,952
20,202
50,766
8fi,620 P7,387 6fi,856
218,861
1,0I4
19,7 6
120,760
(US}
$ 20,805
1P5,393,558
81.3%
3d.0%
80.9%
0.G%
0.0%
Cost of revenue: Subscription services Term-license
Other non-recurring*
Professional services Total cost of revenue
Gross profit
Operating expenses: Research and development Sales and marketing General and administrative Other
Yr Ended
31- Dec
$ 2D9,75
70,663
280,6J6
13,561
31,135
325,110
19,24 P
13,766
2D,240
53,231
27J ,879
81,38d
110,813
13,113
238,642
33,237
(1fi8,8001
(75,563}
5,537
$ (8,100}
1P0,15J,5£9
83.d%
73.G%
-7.3%
5,798
3,094
1,372
13,2d4
7d,31B
23,197
32,059
11,815
6,39V
4,826
5036
16,261
23,é93
32,320
10,953
3.45
5,378
25,92é
32,48d
13,557
7,15d
Yr Ended
31-Dec
$ 27,028
82,007
353,035
17,285
30,883
401,203
2d,00J
16,200
20,389
é2,593
50,90D
281,704
56,906
|332,890l
(275,984J
7,023
$ (283,007J
209,171,827
8. %
24.5%
33.0%
12.7%
70.2%
6.2%
-2.5%
-70.5%
6.865
5,h03
7,626
V1,425
25,599
35,524
11,575
7,332
3,301
6,857
17,490
P0,05P
27,277
08,768
Total operating expenses Operating (loss] income Financial lexpensel Income, net
Income (loss] before taxes on income TaX lincome] expense
Net Income (loss]
Diluted net ea rnings [loss] per share
Pro-forma weighted average number of shares used to compute diluted net earnings per share
67,071 66,966 71,969 75,698
9,217 12,487 19,£45 15,727
|78,576l (3J,5021 |223,982l 6, 70
(69,329} {22,0 51 (204,537J 9,897
2,013 1,796 2,556 628
$ (7,372} $ (23,8 11 $ (207,093J $ 9,269
196,823,502 198,919,591 208,7D5,08P 2J7,353,éLD
77,791
12,268
7,060
9,328
1,928
$ 7,400
0.07
2J9,3D2,220
Gross margin
R&D % of total revenue S&M % of total revenue G&A % of total revenue
Total Operating Expenses % of total revenues 0perating margin
TaX rate Net margin
85.2%
7?9%
-2.9%
-7P?%
83.fi%
26.8%
33.8%
41.6%
70.fi% 3.0%
-8.2%
-26.9%
85.5%
26.0%
3fi.6%
4 2.7%
18.2%
-193.8%
83.8%
23.5%
32d%
13.4%
14. %
3.Z%
17.7%
83.7%
25.6%
36.0%
0.9%
72.3%
41.6%
40.fi%
46.2%
Nate: This doc ume nt should be read in conjunction with the Company's SEC Filings.
"Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously
Cellebrite DI Ltd. Condensed and Consolidated - Non-GAAP Income Statements (U.S. Dollars in thousands, except share and per share data- unauditedl
31-Mar
QuarterEnded
30-Jun 3D-5ep 31-Dec
Quarter Ended 31-Mar
Revenue:
Subscription services Term-license
Total subscription Other non-recurring* Professional services
Total revenue
$ 62,103 $ 65,738 $ 69,039 $ 73,868
YrEnded
31-Dec
$ 209,751
7fi,663
280,6 6
18,561
3,135
325,1 0
19,219
18,577
273,ddJ
77,866
02,862
37,676
24 a,fl 2
55,282
(1 fi8,8001
5,537
633
11P,348
$ 60,926
$ 0.28
206, P6,081
2J.0%
67.2%
17.0%
-9.2%
18.7%
17,1J9 9,630 26,D38 21,220 79,222 85,368 93,377 95,068
8,568 3.686 3,938 6,2P8
6,792 6,860 9,563 7,688
89,582 95,71I 06,858 09,049
$ 76,688
9, 6
95,829
6,61J
7,309
07,549
Cost of revenue: Subscription services Term-license
Other non-recurring*
5,7P8
3,057
d,399 1,783
3,372
7,15d
G,835
7,013
3,01J
Professional services
0,P77
4,8d2
5,058
d,d83
Total cost of revenue
Gross profit Operating expenses:
Research and development Sales and marketing General and administrative
Total operating expenses
Non-GAAP operating income lloss] Financial Income, net
Income (loss] before taxes on income TaX lincomel expense
Income tax adjustment
0ne time taX (income] expense
1 2,832
YrEnded
31-Dec
$ J55,890
6fi,053
215,963
21,265
33,663
270,651
1 7, 07
687
1 2,865
19,003
221,189
7,069
91,352
36,23O
19,538
1 19,716
139,25*
I38J]
(2,3d8]
(116,883]
$ 19,684
$ 0.10
195,390, 558
270%
33.8%
74.5%
72%
-1.5%
7.3%
7d,750
20,960
2P,815
10,096
60,871
15,879
178,5761
(62,697)
20 3
1233]
15,598
80,11é
21,032
30,D02
8,P7d
6 D,31 D
19,806
1345021
(14,6961
1 796
837
14,885
91,973
23,G36
29,éd5
9,366
62,467
29,506
1Z239821
(194,476
2556
(30B
17,049
92,000
22,P20
32,27D
9,882
65,072
2é,928
4,170
31,098
628
|6,367J
16,740
90,809
24,198
35,69
68,838
21,971
7,0d0
29,031
1,928
Finance (income] expense Non-GAAP net income (lossl
Diluted net earnings [lossl per share
Pro-forma weighted average number of shares used to compute diluted net earnings per share
81,83P 38,580 229,185
$ 16,866 $ 22,925 $ 31,847 $ 26,123
$ 0.08 $ 0.10 $
2 1,256,086 21 ,363,253 22b,882,638 250,509,605
$ 26,179
$ 0.10
252,A56,562
Gross margin
R&D % of total revenue S&M % of total revenue G&A % of total revenue
Total Operating Expenses % of total revenues Operating margin
Tax rate Net margin
23.J%
-2.9%
18.8%
83.7%
22.3%
31.3%
9.zt% d3.0% 20.7%
-17.Y%
8d.1%
27.8%
8.8%
58.5%
-1.2%
29.8%
8G.G%
9. 4%
59.7%
84.4%
22.5%
33.2%
8.3% d4.0% 20.J%
3.5%
Yr Ended
31-Dec
$ 271,028
82,D07
353,fi35
J7.285 30,883
10 ,203
2d,D0J
18,0G7
6D,366
310,839
88,668
1 21,752
08,020
268,72D
92,1 4 9
|332,8901
(260,771 ]
7,023
34P,601
$ 97,761
$ 0.J2
227,258,73 4
8}0%
22.1%
30.3%
9.8%
82.0%
Note: This document should be read in conjunction with the Company's SEC Filings.
*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses. and was previously referred to "Perpetual license and other." Changing the name for this type of revenue reflects that perpetual license
Yr Ended 31- Dec
78.761
6.286
1.731
22.125
12,511
17,259
11,254
15,d53
26,829
80.533
$ 376,464
$ 4,6 4 2
£5,£53 152,709
5,003
207.777
52.173
17,532
2a 18¿
10,353
$ 329.428
100253
73.865
$ €03.293
Cellebrite DI Ltd. Condensed and Consolidated - Balance Sheets ASSETS
Cashand cashequnaets Marketabesecur›tes Trade receivables
N on-current assets
Other non curre nt assets Deferred tax assets, net
Intangible assets, net
0perating lease right-of-use assets, net
Total non-current assets
Liabilities, redeemable convertible preferred shares and shareholders' equity ldeficiency]
Current Liabilities Trade payables
Other accounts payab Ie and accrued expenses
0 perating tease liabilities Total current liabilities
Quarter Ended 31- Mar 30-Jun 30-Sep
Yr Ended 31- Dec
77260
5550
0,050
22.082
7,34J
28,859
7,024
105P4
14260
26.820
83.974
$ 506,056
$ 8,282
££,8£5 195,725
/i,972
253.824
zi7,098 8175
2A .8AP
$ €98.673
|84,896l
1,050
118M3
3f212
$ 532.885
Yr Ended
31- Dec
82,358
5.827
8.930
567.593
7,682
36,604 i4,072
11306
10 OS
28714
122,?74
$ 6P0,567
$ 4 ,077
63,330
216,970
zi,125
295.502
6841
59.045
$ 354.547
498,883
2,086
I1éT8éT
336020
$ 690.5d7
6 4 ,643 70,6P9 93,728
4957 5.516 6.5%
9.250 8.785 9725
378.060 41 751 501. 54
6,732 8,224 7,635
70,706 60,652 £2,834
7,789 8,806 9,292
10.47 9.807 1130
13021 11708 12.080
26.820 26.820 28714
151,077 141,832 127,792
$ 529, 487 $ 556,583 $ 629, 266
$ 7,045 $ 6,5 0 $ 7,276
36,706 £2,259 5£,£84
186,028 183,938 206,682
zi,839 zi,521 zi,zi78 234,618 237,228 272,920
Quarter Ended 31- Mar
81.142
6.260
8,969
523.482
6,897
100,305
11,545
17,76d
$ 709,892
$ 40,244
53,932
219,442
/i,210 287.798
Long-term Liabilities Other long-term liabilities
Long term deferred revenues Price Adjustment Shares liability
66, 432 75,230
4 22,082 43£,758
7,882
6,566
0 perating tease liabilities Total long-term liabilities
Shareholders' equity (defic ie ncy]
Accumulated o+herconnprehensve‹ncome
Total lia bilities, red eemab ie convertible prefe rred shares and sharehold c
321.225 35?51 58.010
$ 555,8€3 $ 596,7€2 $ 330,930
{74,88 I {64,284J 482, 48
1,489 1,250 416
4@771 22@é0 I184,133 I2670d] 401 5g 298,316
$ 529,137 $ 556,583 $ d29, 2€6
a,3P3
58.600
$ 346.398
510.153
890
$ 709.892
Nae: ThsdxumenshouJbereaJ+nxnn#onw heCompa/sSECE'n9s.
Celfebrite DI Ltd. Condensed and Consolidated - Quarterly US GAAP Cash Flows [U.S. Dollars in thousands- unaudited]
Cash flows from operating activities:
Net income llossl
Adjustments to reconcile net income to net cash provided by Iused in] operating activities:
Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec
$ 171,3721 $ 123,811] $ IZ07,093] $ 19,Z59
Quarter Ended 31-Mar
$ 17,400
Share-based compensation and RSU's
Amortization of premium and discount and accrued interest on marketable securities
Depreciation and amortization
Interest income from short-term deposits Deferred tax assets, net
Revaluation of derivative warrants
Remeasurement of Restricted Sponsor Shares liability Remeasurement of Price Adjustment Shares liability [Increase] decrease in trade receivables
Increase (decrease] in deferred revenue Decrease lincrease] in other non-current assets
[Increase] decrease in prepaid expenses and other current assets Changes in operating lease assets
Changes in operating lease liability [Increase] deacrease in inventories Increase (decrease] in trade payables
Increase (decrease] in other accounts payable and accrued expenses [Decrease] increase in other long-term liabilities
Net cash [used inl provided by operating activities
Cash flows from investing activities: Purchase of property and equipment Purchase of intangible assets
5,d9d d,555
Yr Ended
31-Dec
$ 120,805
13.708 l372]
9,194
ld84
f27,l80J f53,220J f12,B85J
227
4,d67
|3,680l
|5,47II
|B,853I
20,577
|6,897l
|2,488l f8S,864J 22,277
fi5,05SJ
191,231]
4 ,3fl7
13,970
l56,68aJ
|I,644I 445,S73
87,665
$ 9,O53
$ 142
$ 664
$
$
$
$
Yr Ended
31-Dec
$ 181,1 OOI
18.998
l1,10dj 10,011
77371
2S,7I5
55,531
2,271 l5,d1D1 4,362
248
3,691
784
402,058
|5,28ll
|2,687l f55,817J 56,336
fi5,664J
I22,540J
2,628
24 ,765
404,283
585
87,645
489,517
$ 10,047
$
$
$ 4,363
$
$
$
l517] [755]
2,680 2,576
|2,828l I2,6421
22,587 46,806
1 B,B85 9,058
40,367 42,676
15,258 f9,2871
f13,406J f1,6491
605 f1,4S2l
4,S67 7B5
11,2691 [1,273]
d77 474
1O,0$1 1$.513
|l,495l f2,07fll
|625J f279l
V.055
{73@1
2,d22 [2,430]
[634]
71,271
37,906
1 20,008
20,11 7
5B9
3,334
1,244
H ,019]
[US]
P,184
831
6 4 ,650
I1,8201
P,28P
l8dd]
2,729
10,268
17,255
f47l
|2,885l 4,450
|I,278I 746
3,517
11,722
|S28J 65,967
|3, 4 781
|l,48Sl
8,777
[523]
I2,flB0l f886l
1,721
7B5
5,6B0
1,15d [1,179] l10] [1,046]
f888l 20,878
Investment in marketable securities
Proceeds from maturities of marketable securities
Payment related to business combination, net of cash acquired
f68,892J |30,8S0J
15,045 20,3SI
|lfl,428l f15,07SJ
48,550 10,585 f2,7481
77,419
Short-term deposits, net
Net cash [used inl provided by investing activities
f26,1281 |20,al3l |I6,2I9I |7,588J I81,595J |33,264l |18,665l I15,949J
121,628] [12d,504]
Cash flows from financing activities: Exercise of warrants, net
Exercise of options to shares Proceeds from ESPP, net
Net cash provided by financing activities
4,319
750
5,08P
2,568
756
3,324
4,622
8b4 5.528
5,75d
Yr Ended
31-Dec
$ |283,007I
30575
12,904d
10,807
(0,7381
14,0151
4 10,664
65,B89
478,054
|5,82SI 22,317
|364J 3,201
5,3fl5
|4,88SI 582
2,755
17,586
880
432,171
|B,566I
|2,043l
|I27,78SJ 5S,S7I
|2,748l
f68,298J
|1é9,a73J
17,2d5
3,344
20,651
3,369
|I,207I 485,517
$ J9J,659
$ 7,706
$
$
$ 1,884
$ 161,770
$ 113,136
$ 251,7dd
974 d,730
2,4P3
1,127
3,620
Net ldecreasel increase in cash and cash equivalents and restricted cash Net effect of currency translation on cash and cash equivalents
Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period
Supplemental cash flow information:
Cash paid for taxes
Purchase of property and equipment on suppliers' credit Purchase of intangible assets
Operating lease liabilities arising from obtaining right of use assets Reclassification of warrants from liability to equity
Reclassification of Restricted Sponsor Shares from liability to equity
Reclassification of Price Adjustment Shares from liability to equity
Note: This document should be read in conjunction with the Company's SEC Filings.
l66,a85J |15,427l 28,513 56,768
|600J |49l 8B0 |I,488I 485,517 122,482 106,956 486,84S
$ J22,é32 $106,956 $ 136,3é9 $ J9J,659
$ 7V1 $ 1,766 $ 1,348 $ 3,801
$ $ $ $
$ $ $ $
$ 87 $ 126 $ 1,616 $ 53
$ $ $ 1d1.770 $
$ $ $ 113.136 $
$ $ $ 251.7dd $
1102,0061
822
151,659
$ 90,675
$ 806
$
$
$
$
$
$
FY 202¥
FY 2023
FY 2022 |
3 - Dec
34 -Dec
34 -Mar
30-dun
30-Sep
3 - Dec
yr Ended 31- Dec
Ended
31- Mar
$ 2J 9,905 $ 27J ,879 $ 76,34 8
? ,286 I ,733 630
$ 79,653
663
9 4 ,625
$ 338,6 0
559
90,059
750
$ 224 , 489 $ 273,66G
$ 76,750
$ 80 4 6
$ 91,973 $ 92 000
$ 3G0,839 $ 90 809
$ 218,861
$ 238,6zi2
$ 67,071
$ bb,966
$ 71,9 69 $ 75,b98
$ 281,70zi $ 77,791
5,892
8,696
28,3G8
8,027
2,826
3,367
927
43708
18.998
5A96
d,555
9,055
9,269
30,575
8,777
19,538
55.282
$ 15,879
$ 19.0Q6
$' 29,506
$ 26.928
92,119 $ 24 .97 4
$1 20,805 $ l84 ,400 $ | 7 ,372J
$ 123,8 4 4I $ | 207,093J $ 9,269
$ | 283,007 $ 7,600
2,368
?3,708
2,826
?,960
|381
|JJ6863
9,687*
J8,P98 5,696
3,367 927
66 9
633 |233J
419368 8J 839
60,926 $1 6,866
6,555
766
-837
38580
$ 22,925
9,055
79G
212
|306J 229 J85
$ 31 ,867
9,269
30,575
8,777
92d
221
{92Gl
$ 26, 1 23
3¥P 6DX
87,761
$ Z6,178
$ J20,80b $ {81,i00 $ l7i,372J
|JJ9,7J6 J08,800 78,576
|6b 5,537 2,063
9,49G J0,044 2,680
$ {23,8111
36,502
J,796 2,576
$ I207,093J 223,982
2,556
2,622
9,269
$ | 283,007
628
2,729
7,023
40,607
,928
43,708
8,998
5,696
6,555
9,055
9,269
30,575
8,777
GAAP to Non‐GAAP Reconciliations
1,28zi
1,733
663
559
575
2,227
750
N on - GAAP cost of reven ue
$' 49,462
$ 51.446
$ 12,832
$ 15.598
$'
1 zi,885
$ 17.049
$' 6Q,g6zi
$ 16.740
Share- ba sed compensatlon expense
Non- GAAP gross profit
0 perating ex pen ses
Acquisition-related costs
? ,960
{7
7
212
Non- GAAP operating expenses
$ 201,651
$ 218,382
$ 6Q,871
$ 60.310
$ 62,467
$ 65.072
$ 2J8,72Q
$ 68.OPB
Dvifi end pa rti c1pati o n en m pe nsat io n Amortization of Intangi bfe assets
Dvifi end pa rti c1pati o n en m pe nsat io n Amortization of Intang ibfe assets
Non- GAAP operating income |loss)
Share- ba sed compensatlon expense
Acquisition re dated costs
Non- GAAP net income lloss]
Dvifi end pa rti c1pati o n en m pe nsat io n
Adjusted EBITDA margin
Cellebrite DI Ltd. - Revenue Mix
(U.S. Dollars in thousands - unaudited]
Revenue by geography: Americas
EM EA
APAC
Total revenue
Revenue % of total:
Americas EM EA APAC
Total revenue
Quarter Ended
31- Mar 30-Jun 30-Sep 31- Dec
Yr Ended
31- Dec
$ 172.154
112,2 7
40.709
$ 32/J,11O
53.0%
34.5%
12.5%
100.0%
316
166
111
36
125%
$ 46.473 $ 50.895 $ 59.618 $ 58.545
33,202 31,89 32,823 37,002
9907 12.925 14.417 13.502
$89,582 $9/J,714 $ 106,858 $ 109,049
51.9% 53.2% 55.8% 53.7%
37.1% 33.3% 30.7% 33.9%
11.1% 13.5% 13.5% 12.4%
100.0% 100.0% 100.0% 100.0%
Quarter Ended 31- Mar
Yr Ended
31- Dec
$ 215531
13 921
50751
$ 401,203
53.7%
33.6%
12.6%
100.0%
396
215
13J
17
12G%
$ 56.531
37, 21
13.597
$ 107,549
52£%
3A.8%
12£%
100.0%
Yr Ended
31- Dec
$ 141923
92779
35949
$ 270,651
524%
3J.3%
13.3%
100.0%
249
128
93
28
130%
Annual recurring revenue [in millions] America
EMEA APAC
Recurring revenue net dollar-based retention rate
Note: This document should be read in conjunction with the Company's SEC Filings.
332
17J
119
39
125%
183
121
42
124%
371
199
128
124%
396
215
G7
124%
408
221
137
50
121%
Disclaimer
Cellebrite DI Ltd. published this content on May 14, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 14, 2025 at 12:04 UTC.